A phase 3 study of biosimilar BI 695501 versus adalimumab in patients with Crohn’s disease - VJBM
Вставка
- Опубліковано 27 вер 2024
- In this video, Professor Stephen Hanauer presents the results from the phase III VOLTAIRE-CD study: comparing the safety and efficacy of BI 695501 versus adalimumab in patients with Crohn’s disease.
Subscribe: www.youtube.co...
Visit The Video Journal of Biomedicine: www.biomedicin...
Follow us on Twitter: / vjofbiomedicine
LinkedIn: / video-journal-of-biome...
Facebook: / videojournalbiomedicine